Tuesday, March 29, 2016

BRIEF-Durect licensee, Pain Therapeutics resubmitts NDA for Remoxy to U.S. FDA

* Durect announces resubmission of Remoxy New Drug Application to the U.S. Food and Drug Administration


Read more
Posted by at

No comments:

Post a Comment

Subscribe to: Post Comments (Atom)